NCT00005660
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +30 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Hypertriglyceridemia
Explore clinical trials studying Hypertriglyceridemia. Study availability and eligibility vary by location and protocol.
258 public trials
21 recruiting studies
Hypertriglyceridemia trial results
NCT00134498
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Pfizer Investigational Site Anaheim, California, United States
- Pfizer Investigational Site Huntington Beach, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Orange, California, United States
Active, Not Recruiting
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
NCT02262806
- Conditions
- Diabetes, Diabetes Mellitus, Dyslipidemias, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
NCT02262832
- Conditions
- Diabetes, Diabetes Mellitus, Dyslipidemias, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
NCT06347003
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Research Center 1 Garden Grove, California, United States
- Research Center 2 Lake Forest, California, United States
- Research Center 3 Montclair, California, United States
- Research Center 4 Panorama City, California, United States
Active, Not Recruiting
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
NCT06347133
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
- Locations
-
- Research Site 1 Birmingham, Alabama, United States
- Research Site 2 Mobile, Alabama, United States
- Research Site 3 Beverly Hills, California, United States
- Research Site 4 Canoga Park, California, United States
Active, Not Recruiting
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
NCT07028749
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
- Locations
-
- Marea Site 328 Anniston, Alabama, United States
- Marea Site 329 Mobile, Alabama, United States
- Marea Site 313 Little Rock, Arkansas, United States
- Marea Site 306 Hamden, Connecticut, United States
Active, Not Recruiting
Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO
NCT07530575
- Conditions
- Body Weight, Cardiovascular Diseases, Cholesterol (Total and HDL), +27 more
- Locations
-
- Raul Francisco Pastor Buenos Aires, Buenos Aires City, Argentina
- TIEMPO MEDICO Health Research Center Buenos Aires, Argentina
Active, Not Recruiting
WB-EMS Effects on Cardiometabolic Risk Factors
NCT07406191
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemias, +19 more
- Locations
-
- Faculty of Medicine, University of Tuebingen Erlangen, Germany
- Institute of Radiology, University Hospital Erlangen Erlangen, Germany
Active, Not Recruiting
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
NCT06548100
- Conditions
- Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus, +28 more
- Locations
-
- National Institutes of Health Bethesda, Maryland, United States
- University of Michigan Ann Arbor, Michigan, United States